This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S, Gadner H, Lion T . Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection Leukemia 1999 13: 2060–2069
Peters C, Matthes-Martin S, Fritsch G, Holter W, Lion T, Witt V, Hoecker P, Fischer G, Dieckmann K, Handgretinger R, Klingebiel T, Gadner H . Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment Leukemia 1999 13: 2070–2078
Bader P, Beck J, Frey A, Schlegel PG, Hebart H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T . Serial and quantitative analysis of mixed haematopoietic chimerism by PCR in patients with acute leukaemia allows the prediction of relapse after allogeneic BMT Bone Marrow Transplant 1998 21: 487–495
Thiede C, Bornhaeuser M, Oelschlaegel J, Brendel C, Leo R, Daxberger H, Mohr B, Florek M, Kroschinsky F, Geissler G, Naumann R, Ritter M, Prange-Krex G, Lion T, Neubauer A, Ehninger G . Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers Leukemia 2000 (in press)
Lion T, Daxberger H, Dubovsky J, Filipcik P, Fritsch G, Peters C, Matthes-Martin S, Lawitschka A, Gadner H . Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation Leukemia 2000 (in press)
Lion T, Muller-Berat N . Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical-biological situations (Debate-Round Table) Leukemia 1999 13: 2059
Bader P, Hölle W, Klingebiel T, Handgretinger R, Niethammer D, Beck J . Quantitative assessment of mixed haematopoietic chimerism by PCR after allogeneic bone marrow transplantation Anticancer Res 1996 16: 1759–1764
Bader P, Hölle W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG, Niethammer D, Beck J . Mixed haematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children Bone Marrow Transplant 1997 19: 697–702
Bader P, Beck J, Schlegel PG, Handgretinger R, Niethammer D, Klingebiel T . Additional immunotherapy on the basis of increasing mixed haematopoietic chimerism after allogeneic BMT in children with acute leukaemia: is there an option to prevent relapse? Bone Marrow Transplant 1997 20: 79–81
Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P, Niethammer D, Beck JF . Prevention of relapse in paediatric patients with acute leukaemia's and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children Leukemia 1999 13: 2079–2086
Sacks H, Chalmers TC, Smith H . Randomized versus historical controls for clinical trials Am J Med 1982 72: 233–240
Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermüller J, de Witte T, Holler E, Ansari H . Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041–2050
Armitage P, Berry G . The size of a statistical investigation. In: Armitage P, Berry G (eds) Statistical Methods in Medical Research, 3rd edn Blackwell Science: London 1998 pp 195–206
Lilford RJ, Thornton JG, Braunholtz D . Clinical trials and rare disease: a way out of a conundrum British Med J 1995 311: 1621–1625
Siep L, Ethische Aspekte der Forschung mit nicht-einwilligungsfähigen Personen . In: Honnefelder L, Streffer C (eds). Jahrbuch für Wissenschaft und Ethik, Band 4 Walter de Gruyter: Berlin, New York 1999; pp 115–125
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klingebiel, T., Niethammer, D., Dietz, K. et al. Progress in chimerism analysis in childhood malignancies – the dilemma of biostatistical considerations and ethical implications. Leukemia 15, 1989–1991 (2001). https://doi.org/10.1038/sj.leu.2402315
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402315
This article is cited by
-
Chimerism and transplant-related diagnostics
Leukemia (2006)
-
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective
Bone Marrow Transplantation (2004)
-
Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood
Leukemia (2003)
-
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience
Leukemia (2003)
-
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience
Leukemia (2003)